Lyrus logo — Lyrus is a research and development (R&D) organisation doing...

Lyrus

Lyrus is a research and development (R&D) organisation doing contract drug development & manufacturing #CDMO

Founded 2015 India India 112 employees Life Sciences, Manufacturing +1

General Information

Company Name Lyrus
Founded Year 2015
Location India India +1
Employees 112
Industries Life Sciences, Manufacturing, Pharmaceutical
Social

Get notified when Lyrus moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Lyrus

Lyrus is an India-based research and development (R&D) organization specializing in contract drug development and manufacturing (CDMO). With a focus on creating innovative pharmaceutical products, Lyrus aims to enhance the quality of life for individuals. The company's leadership team boasts over 300 years of combined experience in pharmaceutical formulation development, manufacturing, and marketing on a global scale, establishing a reputation as a trusted partner for major MNCs such as Pfizer, Novartis, Sanofi-Aventis, and GSK. Lyrus has evolved into a full-spectrum Contract Research & Development Organization, equipped with state-of-the-art technology and machinery to cover the entire value chain. The company's key highlights include collaboration with leading pharmaceutical firms, the capacity to develop over 60 challenging products annually, expertise in various platform technologies, and an extensive range of Nutraceutical and OTC products. Lyrus's capabilities encompass the development of major dosage forms, including oral solids, oral liquids, topical, parenteral, and more. Despite lacking specific details about recent investment, Lyrus presents a compelling proposition within the Manufacturing and Pharmaceutical industries. The company's extensive experience, coupled with its commitment to innovation, positions it as a formidable player in the biotechnology, pharmaceuticals, diagnostics, healthcare, immunology, and personalized healthcare sectors. Overall, Lyrus appears to be a promising venture with the potential to attract interest from investors seeking opportunities in the pharmaceutical and biotechnology space.

Taxonomy: Contract Drug Development, Pharmaceutical Manufacturing, Research & Development, Diagnostics, Immunology, Drug Delivery Systems, Nutraceuticals, OTC Products, Innovation, Generic Medicines, Biosimilars

No funding data available for Lyrus yet.

Get notified when Lyrus raises funding

Lyrus Alternatives & Competitors

Lyrus vs
Slayback Pharma
Slayback Pharma United States

Slayback Pharma believe every pharmaceutical product exhibits its own unique personality

Acquired
41 employees
Biopharma, Manufacturing
Lyrus vs

Contract Development and Manufacturing Organization- Oral Solids, Oral Liquids, Topicals, Injectable...

236 employees
Lyrus vs

International One-stop CDMO Platform for Pharmaceutical Development and Manufacturing

7 employees
Health Care, Manufacturing

FAQ About Lyrus

Lyrus is a research and development (R&D) organisation doing contract drug development & manufacturing #CDMO
Lyrus was founded in 2015.
Lyrus is headquartered in India.
Lyrus operates in the following industries: Life Sciences, Manufacturing, Pharmaceutical.
Lyrus has approximately 112 employees.
Top alternatives and competitors to Lyrus include Slayback Pharma, Axxelent Pharma Science Pvt Ltd, Visum Pharmaceutical, Molecular Formulations, Athena Pharmaceutiques S.A.S.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lyrus and Slayback Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Lyrus and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy